1st Quarter - Report

PREMIER, INC. for PREMIER, INC.

Firm
Client
Income
—
Expenses
$220,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Incentivizing domestic manufacturing of critical medical supplies Issues related to health care costs and transparency Electronic prior authorization and administrative simplification Health care supply chain resiliency 340B Drug discount program Reauthorization of Pandemic and All Hazards Preparedness Act Hospital finance issues Healthcare workforce issues (graduate medical education, health professional training, recruitment and retention Medicare payment policies Alternative payment models and related policies Medicare home infusion policy Expanding access to interoperable health tech in long term and post-acute care settings Maternal and infant health Health care workplace violence and worker safety S. 148, Stop STALLING Act Medicaid Disproportionate Hospital Share cuts

LobbyistCovered position, as disclosed
BLAIR GORDON CHILDS —
JOHN KNAPP —
SOUMI SAHA —
SHARA SIEGEL —

Contacted: SENATE; Food & Drug Administration (FDA); Drug Enforcement Administration (DEA); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 148 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.